About Advanced Therapies Europe

Sample Image

Paving the way for new standards in European healthcare

We really believe in Europe. Whether you're an established ATMP player, or are looking to enter into the European market, there is opportunity for everyone. Our purpose is to inspire attendees by celebrating the progress that has been made in Europe over the last few years, helping us move closer to a new standard in healthcare.

Advanced therapies Europe 2020

Advanced Therapies Europe is tailored to a European audience looking to commercialise ATMPs globally, as well as a global audience looking to understand and expand into the European market. By bringing these two groups together, new partnerships can be forged to solidify Europe as a hub for cell and gene therapy.

Advanced therapies Europe 2020

By putting global challenges in a regional context, Advanced Therapies Europe will provide the platform to showcase the diverse array of investment opportunities to early stage biotechs. It will also be the stage for highlighting innovation in Europe to existing, established industry investors.

Why Advanced Therapies Europe?

Phacilitate     This is the only meeting to promote Europe as a hub for advanced therapies

Phacilitate     We promote biotechs moving across the value chain and make it our priority to provide the tools for them to do so 

Phacilitate     We put the needs of biotechs first by hand-selecting investors and suppliers for one-to-one meetings at the event as part of our Phacilitate: MATCH programme

Phacilitate     It is a European meeting that brings in the entire ecosystem across cell, gene and immuno-oncology

Phacilitate     We have unparalleled participation from decision-makers and budget holders

Advanced Therapies Europe 2020    It is a European advanced therapies event for investors which uncovers investment opportunities whilst also serving an educational purpose